Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 13 Pharmaceutical Chemistry (biotechnology) PhD Projects, Programmes & Scholarships

Discipline

Discipline

Chemistry

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Pharmaceutical Chemistry (biotechnology) PhD Projects, Programmes & Scholarships

We have 13 Pharmaceutical Chemistry (biotechnology) PhD Projects, Programmes & Scholarships

Research Assistant (PhD student)

Profile. MSc-degree or equivalent in subject of Chemistry, Biotechnology, Pharmacy with a strong background in Organic Chemistry or Chemical Biology with synthesis. Read more

High-throughput characterization and engineering of nucleotide synthases for production of nucleoside analogues

Nucleotides are the building blocks of life, modulating diverse processes from protein production to cell signalling. It is therefore unsurprising that synthetic nucleoside analogues have been developed as therapeutics for the treatment of a wide range of diseases including cancers and viral infections. Read more

Fully Funded PhD Scholarship in Polarised Fluorescence based Downstream Analytics, NBL-1

Application(s) are invited from suitably qualified candidates for full-time funded PhD scholarship(s) starting in February 2024 affiliated to the Nanoscale Biophotonics Laboratory in the Discipline of Physics (School of Natural Sciences) at the University of Galway. Read more

Fully Funded PhD Scholarship in Antibody Drug Conjugate (ADC) analysis by Polarized Excitation Emission Matric (pEEM) spectroscopy, NBL-3

Application(s) are invited from suitably qualified candidates for full-time funded PhD scholarship(s) starting in February 2024 affiliated to the Nanoscale Biophotonics Laboratory in the Discipline of Physics (School of Natural Sciences) at the University of Galway. Read more

From bench to pre-clinical evaluation: a novel nucleic acid vaccine targeting tumour-associated antigens

Cancer and the long-term toxicities sustained from treatment remain a public health issue for adult and paediatric patients. The spread of tumour cells is believed to account for up to 90% of cancer-related morbidities. Read more

New strategies to cryopreserve cell-based therapies

In the past decade, cell-based therapies have emerged to transform the treatment of disease, particularly cancer. Whilst potent, these therapies are challenging to deliver in practise as must be stored frozen (cryopreserved). Read more

Discovery of Novel Cancer Immunotherapeutic Agents

Summary. Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality. Read more

Discovery of New Treatments for Parkinson’s disease

Summary. Parkinson’s disease (PD) is the second most common neurological disease in the world. Current PD therapies and medical interventions are very limited and only address the symptoms of this disease highlighting the need for new and effective treatments for this disease. Read more

EPSRC CDT in Bioprocess Engineering Leadership: Complex Biological Products Manufacture

Biological products and their manufacture are progressing to unparalleled levels of complexity. Examples include engineered biocatalysts, antibody-drug conjugates, multivalent vaccines and cellular therapies. Read more

Development of LA1011 for high affinity binding to Hsp90 for use towards healthy ageing in patients showing Alzheimer’s symptoms

  Research Group: Biochemistry
With 50 million global cases of Alzheimer’s disease (AD) and care costs of 1 trillion UK pounds (expected to triple by 2050), there is a pressing need to slow disease progression, sustain productive lives and reduce costs. Read more
  • 1

Filtering Results